NCT01765049

Breast Density Change Predicting Response to Adjuvant Aromatase Inhibitor

Prospective Study Analyzing Value of Breast Density Change Predicting ENdocrine Therapy Response in Postmenopausal Women Taking Adjuvant ARomatase Inhibitor

• Status: Unknown
• Phase: —
• Study type: Observational
• Enrollment: 260 (actual)
• Sponsor: Seoul National University Hospital · Academic / Other
• Sex: Female
• Age: 70 Years
• Healthy volunteers: Not accepted

Summary

Breast density change after short term use of aromatase inhibitor in postmenopausal ER positive breast cancer would predict endocrine responsiveness

Detailed description

Inclusion criteria ER positive breast cancer Postmenopause women Older than 60yr S/P bilateral salphingo-oophorectomy No menstruation history within 1yr and FSH\>30mIU/mL Ipsilateral invasive breast cancer Undergone curative resection No evidence of distant metastasis Capable of breast MRI

Conditions

• Invasive Breast Cancer
• Estrogen Receptor Positive Breast Cancer

Timeline

• Start date: 2013-01-01
• Primary completion: 2025-12-15
• Completion: 2025-12-15
• First posted: 2013-01-10
• Last updated: 2022-10-18

Locations

1 site across 1 country: South Korea